About Forward Clinical Trials, Inc.
Clinical Trials at Forward Clinical Trials, Inc.
During the past decade, Forward Clinical Trials, Inc. conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 15 clinical trials were completed, i.e. on
average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 11 clinical trials were completed. i.e. 220%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Forward Clinical Trials, Inc." #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Pfizer" with 4 trials
sponsored, "Asana BioSciences" with 3 trials sponsored, "Incyte Corporation" with 3 trials sponsored and "Almirall, S.A."
with 3 trials sponsored. Other sponsors include 3 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Forward Clinical Trials, Inc."
#1 collaborator was "Athenex, Inc." with 2 trials as a collaborator, "Innovaderm Research" with 1 trials as a collaborator and "Novum Pharmaceutical Research Services" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Forward Clinical Trials, Inc.
According to Clinical.Site data, the most researched conditions in "Forward Clinical Trials, Inc." are
"Atopic Dermatitis" (9 trials), "Alopecia Areata" (3 trials), "Actinic Keratosis" (2 trials), "Dermatitis, Atopic" (2 trials) and "Plaque Psoriasis" (2 trials). Many other conditions were trialed in "Forward Clinical Trials, Inc." in a lesser frequency.
Clinical Trials Intervention Types at Forward Clinical Trials, Inc.
Most popular intervention types in "Forward Clinical Trials, Inc." are "Drug" (24 trials) and "Other" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (14 trials), "ASN002" (3 trials), "Mirikizumab" (2 trials), "PF-06700841" (2 trials) and "Placebo Oral Tablet" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Forward Clinical Trials, Inc.
The vast majority of trials in "Forward Clinical Trials, Inc." are
24 trials for "All" genders.
Clinical Trials Status at Forward Clinical Trials, Inc.
Currently, there are NaN active trials in "Forward Clinical Trials, Inc.".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 20 completed trials in Forward Clinical Trials, Inc.,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Forward Clinical Trials, Inc., 2 "Phase 1"
clinical trials were conducted, 12 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".